“Subcutaneous Administration of Tocilizumab Is Effective in Myointimal Hyperplasia Remodelling in Refractory Takayasu Arteritis”. Reumatismo, vol. 69, no. 4, Dec. 2017, pp. 184-8, https://doi.org/10.4081/reumatismo.2017.1013.